227
Views
10
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLES

Ultra-low-dose estradiol and norethisterone acetate: bleeding patterns and other outcomes over 52 weeks of therapy

, , , &
Pages 419-425 | Received 09 Sep 2014, Accepted 14 Dec 2014, Published online: 12 Feb 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

R. Bonassi Machado, L. de Melo Pompei, E. A. P. Nahas, J. Nahas-Neto, L. da Costa-Paiva, S. Y. O. Del Debbio, M. Badalotti, M. C. O. Wender & A. M. Cruz. (2023) Efficacy and safety of ultra-low-dose estradiol and norethisterone in postmenopausal Brazilian women. Climacteric 26:4, pages 401-407.
Read now
J. H. Pickar, D. F. Archer, S. R. Goldstein, R. Kagan, B. Bernick & S. Mirkin. (2020) Uterine bleeding with hormone therapies in menopausal women: a systematic review. Climacteric 23:6, pages 550-558.
Read now
Yang Song, Wenxian Xu, Namratta Devi Chatooah, Jianfang Chen, Yizhou Huang, Peiqiong Chen, Yibing Lan, Chunming Li, Qian Ying, Linjuan Ma & Jianhong Zhou. (2020) Comparison of low dose versus ultra-low dose hormone therapy in menopausal symptoms and quality of life in perimenopause women. Gynecological Endocrinology 36:3, pages 252-256.
Read now
Risa Kagan, Paula Abreu & Emma Andrews. (2018) Vaginal bleeding/spotting with conjugated estrogens/bazedoxifene, conjugated estrogens/medroxyprogesterone acetate, and placebo. Postgraduate Medicine 130:8, pages 687-693.
Read now
Sumika Matsui, Toshiyuki Yasui, Kana Kasai, Kaoru Keyama, Kanako Yoshida, Takeshi Kato, Hirokazu Uemura, Akira Kuwahara, Toshiya Matsuzaki & Minoru Irahara. (2017) Sex hormone-binding globulin and antithrombin III activity in women with oral ultra-low-dose estradiol. Journal of Obstetrics and Gynaecology 37:5, pages 627-632.
Read now

Articles from other publishers (5)

Lucia Costa-Paiva, Maria Celeste O Wender, Rogerio B Machado, Luciano M Pompei, Eliana A Nahas, Jorge Nahas-Neto, Sonia Y Del Debbio, Mariangela Badalotti & Achilles M Cruz. (2022) Effects of ultra-low dose hormone therapy on biochemical bone turnover markers in postmenopausal women: A randomized, placebo-controlled, double-blind trial. Post Reproductive Health 28:3, pages 149-157.
Crossref
N. Hamdaoui & L. Boubli. (2021) La gestion des effets secondaires sous traitement hormonal de la ménopause : saignements utérins anormaux. RPC Les femmes ménopausées du CNGOF et du GEMVi. Gynécologie Obstétrique Fertilité & Sénologie  49:5, pages 474-484.
Crossref
Ya.Z. Zaidieva & V.D. Kazantseva. (2021) Comparative analysis of the prevalence of abnormal uterine bleeding in postmenopausal women against the background of various menopausal hormone therapy (systematic review). Rossiiskii vestnik akushera-ginekologa 21:6, pages 51.
Crossref
Haitham Hamoda, Nick Panay, Hugo Pedder, Roopen Arya & Mike Savvas. (2020) The British Menopause Society & Women’s Health Concern 2020 recommendations on hormone replacement therapy in menopausal women. Post Reproductive Health 26:4, pages 181-209.
Crossref
Salwa Abdullahi Idle & Haitham Hamoda. (2019) Outcomes of endometrial assessment in women with unscheduled bleeding on hormone replacement therapy. Post Reproductive Health 25:2, pages 95-99.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.